Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

JM, Baeten; D, Donnell; P, Ndase; NR, Mugo; JD, Campbell; J, Wangisi; JW, Tappero; EA, Bukusi; CR, Cohen; E, Katabira; A, Ronald; E, Tumwesigye; E, Were; KH, Fife; J, Kiarie; C, Farquhar; G, John-Stewart; A, Kakia; J, Odoyo; A, Mucunguzi; E, Nakku-Joloba; R, Twesigye; K, Ngure; C, Apaka; H, Tamooh; F, Gabona; A, Mujugira; D, Panteleeff; KK, Thomas; L, Kidoguchi; M, Krows; J, Revall; S, Morrison; H, Haugen; M, Emmanuel-Ogier; L, Ondrejcek; RW, Coombs; L, Frenkel; C, Hendrix; NN, Bumpus; D, Bangsberg; JE, Haberer; WS, Stevens; JR, Lingappa; C, Celum

doi:10.1056/nejmoa1108524

Public

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Published in The New England journal of medicine • Jul 11, 2012

NobleIDark:/48914/w1/20260526/AF896500Record on NobleID

Authors:

Baeten JM

,

Donnell D

,

Ndase P

Abstract

Background Antiretroviral preexposure prophylaxis is a promising approach for preventing human immunodeficiency virus type 1 (HIV-1) infection in heterosexual populations.Methods We conducted a randomized trial of oral antiretroviral therapy for use as preexposure prophylaxis among HIV-1-serodiscord...

Discussions